Experiments using chemical depletion (clodronate), genetic models (CD169-DTR mice), or antibody blockade (anti-CSF1R) showed that macrophage ablation results in reduced islet vascular density and volume, impaired insulin secretion, glucose intolerance, and the collapse of compensatory hyperinsulinemia. The gene discussed is INS; the disease is hyperinsulinism.